Global Albumin (as Excipient) Market Growth 2020-2025

  • receipt Report ID : 62551
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 163
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this study, over the next five years the Albumin (as Excipient) market will register a 6.3%% CAGR in terms of revenue, the global market size will reach $ 5262.5 million by 2025, from $ 4120.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Albumin (as Excipient) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (as Excipient) market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Albumin (as Excipient), covering the supply chain analysis, impact assessment to the Albumin (as Excipient) market size growth rate in several scenarios, and the measures to be undertaken by Albumin (as Excipient) companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Human Serum Albumin

Recombinant Albumin

In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Cell Culture Media

Medical Supplements

Therapeutics

Therapeutics had the highest share of sales by application, at 73.27% in 2019.

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

CSL

Albumedix

Grifols

Octapharma

Hualan Bio

Takeda

Kedrion

CBPO

LFB Group

Shanghai RAAS

Biotest

HiMedia

Ventria (InVitria)

Merck

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Albumin (as Excipient) consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Albumin (as Excipient) market by identifying its various subsegments.

Focuses on the key global Albumin (as Excipient) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Albumin (as Excipient) with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Albumin (as Excipient) submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Albumin (as Excipient) Consumption 2015-2025

2.1.2 Albumin (as Excipient) Consumption CAGR by Region

2.2 Albumin (as Excipient) Segment by Type

2.2.1 Human Serum Albumin

2.2.2 Recombinant Albumin

2.3 Albumin (as Excipient) Consumption by Type

2.3.1 Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

2.3.2 Global Albumin (as Excipient) Revenue and Market Share by Type (2015-2020)

2.3.3 Global Albumin (as Excipient) Sale Price by Type (2015-2020)

2.4 Albumin (as Excipient) Segment by Application

2.4.1 Cell Culture Media

2.4.2 Medical Supplements

2.4.3 Therapeutics

2.5 Albumin (as Excipient) Consumption by Application

2.5.1 Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

2.5.2 Global Albumin (as Excipient) Value and Market Share by Type (2015-2020)

2.5.3 Global Albumin (as Excipient) Sale Price by Type (2015-2020)

3 Global Albumin (as Excipient) by Company

3.1 Global Albumin (as Excipient) Sales Market Share by Company

3.1.1 Global Albumin (as Excipient) Sales by Company (2018-2020)

3.1.2 Global Albumin (as Excipient) Sales Market Share by Company (2018-2020)

3.2 Global Albumin (as Excipient) Revenue Market Share by Company

3.2.1 Global Albumin (as Excipient) Revenue by Company (2018-2020)

3.2.2 Global Albumin (as Excipient) Revenue Market Share by Company (2018-2020)

3.3 Global Albumin (as Excipient) Sale Price by Company

3.4 Global Albumin (as Excipient) Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Albumin (as Excipient) Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Albumin (as Excipient) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Albumin (as Excipient) by Regions

4.1 Albumin (as Excipient) by Regions

4.2 Americas Albumin (as Excipient) Consumption Growth

4.3 APAC Albumin (as Excipient) Consumption Growth

4.4 Europe Albumin (as Excipient) Consumption Growth

4.5 Middle East & Africa Albumin (as Excipient) Consumption Growth

5 Americas

5.1 Americas Albumin (as Excipient) Consumption by Countries

5.1.1 Americas Albumin (as Excipient) Consumption by Countries (2015-2020)

5.1.2 Americas Albumin (as Excipient) Value by Countries (2015-2020)

5.2 Americas Albumin (as Excipient) Consumption by Type

5.3 Americas Albumin (as Excipient) Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Albumin (as Excipient) Consumption by Regions

6.1.1 APAC Albumin (as Excipient) Consumption by Regions (2015-2020)

6.1.2 APAC Albumin (as Excipient) Value by Regions (2015-2020)

6.2 APAC Albumin (as Excipient) Consumption by Type

6.3 APAC Albumin (as Excipient) Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Albumin (as Excipient) by Countries

7.1.1 Europe Albumin (as Excipient) Consumption by Countries (2015-2020)

7.1.2 Europe Albumin (as Excipient) Value by Countries (2015-2020)

7.2 Europe Albumin (as Excipient) Consumption by Type

7.3 Europe Albumin (as Excipient) Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Albumin (as Excipient) by Countries

8.1.1 Middle East & Africa Albumin (as Excipient) Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Albumin (as Excipient) Value by Countries (2015-2020)

8.2 Middle East & Africa Albumin (as Excipient) Consumption by Type

8.3 Middle East & Africa Albumin (as Excipient) Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Albumin (as Excipient) Distributors

10.3 Albumin (as Excipient) Customer

11 Global Albumin (as Excipient) Market Forecast

11.1 Global Albumin (as Excipient) Consumption Forecast (2021-2025)

11.2 Global Albumin (as Excipient) Forecast by Regions

11.2.1 Global Albumin (as Excipient) Forecast by Regions (2021-2025)

11.2.2 Global Albumin (as Excipient) Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast byRegions

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Albumin (as Excipient) Forecast by Type

11.8 Global Albumin (as Excipient) Forecast by Application

12 Key Players Analysis

12.1 CSL

12.1.1 Company Information

12.1.2 Albumin (as Excipient) Product Offered

12.1.3 CSL Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 CSL Latest Developments

12.2 Albumedix

12.2.1 Company Information

12.2.2 Albumin (as Excipient) Product Offered

12.2.3 Albumedix Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Albumedix Latest Developments

12.3 Grifols

12.3.1 Company Information

12.3.2 Albumin (as Excipient) Product Offered

12.3.3 Grifols Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Grifols Latest Developments

12.4 Octapharma

12.4.1 Company Information

12.4.2 Albumin (as Excipient) Product Offered

12.4.3 Octapharma Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Octapharma Latest Developments

12.5 Hualan Bio

12.5.1 Company Information

12.5.2 Albumin (as Excipient) Product Offered

12.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Hualan Bio Latest Developments

12.6 Takeda

12.6.1 Company Information

12.6.2 Albumin (as Excipient) Product Offered

12.6.3 Takeda Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Takeda Latest Developments

12.7 Kedrion

12.7.1 Company Information

12.7.2 Albumin (as Excipient) Product Offered

12.7.3 Kedrion Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Kedrion Latest Developments

12.8 CBPO

12.8.1 Company Information

12.8.2 Albumin (as Excipient) Product Offered

12.8.3 CBPO Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 CBPO Latest Developments

12.9 LFB Group

12.9.1 Company Information

12.9.2 Albumin (as Excipient) Product Offered

12.9.3 LFB Group Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 LFB Group Latest Developments

12.10 Shanghai RAAS

12.10.1 Company Information

12.10.2 Albumin (as Excipient) Product Offered

12.10.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Shanghai RAAS Latest Developments

12.11 Biotest

12.11.1 Company Information

12.11.2 Albumin (as Excipient) Product Offered

12.11.3 Biotest Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 Biotest Latest Developments

12.12 HiMedia

12.12.1 Company Information

12.12.2 Albumin (as Excipient) Product Offered

12.12.3 HiMedia Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.12.4 Main Business Overview

12.12.5 HiMedia Latest Developments

12.13 Ventria (InVitria)

12.13.1 Company Information

12.13.2 Albumin (as Excipient) Product Offered

12.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.13.4 Main Business Overview

12.13.5 Ventria (InVitria) Latest Developments

12.14 Merck

12.14.1 Company Information

12.14.2 Albumin (as Excipient) Product Offered

12.14.3 Merck Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2018-2020)

12.14.4 Main Business Overview

12.14.5 Merck Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Albumin (as Excipient) Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Human Serum Albumin

Table 5. Major Players of Recombinant Albumin

Table 6. Global Consumption Sales by Type (2015-2020)

Table 7. Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

Table 8. Global Albumin (as Excipient) Revenue by Type (2015-2020) ($ million)

Table 9. Global Albumin (as Excipient) Value Market Share by Type (2015-2020) ($ Millions)

Table 10. Global Albumin (as Excipient) Sale Price by Type (2015-2020)

Table 11. Global Consumption Sales by Application (2015-2020)

Table 12. Global Albumin (as Excipient) Consumption Market Share by Application (2015-2020)

Table 13. Global Albumin (as Excipient) Value by Application (2015-2020)

Table 14. Global Albumin (as Excipient) Value Market Share by Application (2015-2020)

Table 15. Global Albumin (as Excipient) Sale Price by Application (2015-2020)

Table 16. Global Albumin (as Excipient) Sales by Company (2017-2019) (MT)

Table 17. Global Albumin (as Excipient) Sales Market Share by Company (2017-2019)

Table 18. Global Albumin (as Excipient) Revenue by Company (2017-2019) ($ Millions)

Table 19. Global Albumin (as Excipient) Revenue Market Share by Company (2017-2019)

Table 20. Global Albumin (as Excipient) Sale Price by Company (2017-2019)

Table 21. Global Albumin (as Excipient) Manufacturing Base Distribution and Sales Area by Manufacturers

Table 22. Players Albumin (as Excipient) Products Offered

Table 23. Albumin (as Excipient) Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 24. Global Albumin (as Excipient) Consumption by Regions 2015-2020 (MT)

Table 25. Global Albumin (as Excipient) Consumption Market Share by Regions 2015-2020

Table 26. Global Albumin (as Excipient) Value by Regions 2015-2020 ($ Millions)

Table 27. Global Albumin (as Excipient) Value Market Share by Regions 2015-2020

Table 28. Americas Albumin (as Excipient) Consumption by Countries (2015-2020) (MT)

Table 29. Americas Albumin (as Excipient) Consumption Market Share by Countries (2015-2020)

Table 30. Americas Albumin (as Excipient) Value by Countries (2015-2020) ($ Millions)

Table 31. Americas Albumin (as Excipient) Value Market Share by Countries (2015-2020)

Table 32. Americas Albumin (as Excipient) Consumption by Type (2015-2020) (MT)

Table 33. Americas Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

Table 34. Americas Albumin (as Excipient) Consumption by Application (2015-2020) (MT)

Table 35. Americas Albumin (as Excipient) Consumption Market Share by Application (2015-2020)

Table 36. APAC Albumin (as Excipient) Consumption by Regions (2015-2020) (MT)

Table 37. APAC Albumin (as Excipient) Consumption Market Share by Regions (2015-2020)

Table 38. APAC Albumin (as Excipient) Value by Regions (2015-2020) ($ Millions)

Table 39. APAC Albumin (as Excipient) Value Market Share by Regions (2015-2020)

Table 40. APAC Albumin (as Excipient) Consumption by Type (2015-2020) (MT)

Table 41. APAC Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

Table 42. APAC Albumin (as Excipient) Consumption by Application (2015-2020) (MT)

Table 43. APAC Albumin (as Excipient) Consumption Market Share by Application (2015-2020)

Table 44. Europe Albumin (as Excipient) Consumption by Countries (2015-2020) (MT)

Table 45. Europe Albumin (as Excipient) Consumption Market Share by Countries (2015-2020)

Table 46. Europe Albumin (as Excipient) Value by Countries (2015-2020) ($ Millions)

Table 47. Europe Albumin (as Excipient) Value Market Share by Countries (2015-2020)

Table 48. Europe Albumin (as Excipient) Consumption by Type (2015-2020) (MT)

Table 49. Europe Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

Table 50. Europe Albumin (as Excipient) Consumption by Application (2015-2020) (MT)

Table 51. Europe Albumin (as Excipient) Consumption Market Share by Application (2015-2020)

Table 52. Middle East & Africa Albumin (as Excipient) Consumption by Countries (2015-2020) (MT)

Table 53. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Countries (2015-2020)

Table 54. Middle East & Africa Albumin (as Excipient) Value by Countries (2015-2020) ($ Millions)

Table 55. Middle East & Africa Albumin (as Excipient) Value Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Albumin (as Excipient) Consumption by Type (2015-2020) (MT)

Table 57. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

Table 58. Middle East & Africa Albumin (as Excipient) Consumption by Application (2015-2020) (MT)

Table 59. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Application (2015-2020)

Table 60. Albumin (as Excipient) Distributors List

Table 61. Albumin (as Excipient) Customer List

Table 62. Global Albumin (as Excipient) Consumption Forecast by Countries (2021-2025) (MT)

Table 63. Global Albumin (as Excipient) Consumption Market Forecast by Regions

Table 64. Global Albumin (as Excipient) Value Forecast by Countries (2021-2025) ($ Millions)

Table 65. Global Albumin (as Excipient) Value Market Share Forecast by Regions

Table 66. Global Albumin (as Excipient) Consumption Forecast by Type (2021-2025) (MT)

Table 67. Global Albumin (as Excipient) Consumption Market Share Forecast by Type (2021-2025)

Table 68. Global Albumin (as Excipient) Value Forecast by Type (2021-2025) ($ Millions)

Table 69. Global Albumin (as Excipient) Value Market Share Forecast by Type (2021-2025)

Table 70. Global Albumin (as Excipient) Consumption Forecast by Application (2021-2025) (MT)

Table 71. Global Albumin (as Excipient) Consumption Market Share Forecast by Application (2021-2025)

Table 72. Global Albumin (as Excipient) Value Forecast by Application (2021-2025) ($ Millions)

Table 73. Global Albumin (as Excipient) Value Market Share Forecast by Application (2021-2025)

Table 74. CSL Product Offered

Table 75. CSL Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 76. CSL Main Business

Table 77. CSL Latest Developments

Table 78. CSL Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 79. Albumedix Product Offered

Table 80. Albumedix Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 81. Albumedix Main Business

Table 82. Albumedix Latest Developments

Table 83. Albumedix Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 84. Grifols Product Offered

Table 85. Grifols Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 86. Grifols Main Business

Table 87. Grifols Latest Developments

Table 88. Grifols Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 89. Octapharma Product Offered

Table 90. Octapharma Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 91. Octapharma Main Business

Table 92. Octapharma Latest Developments

Table 93. Octapharma Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 94. Hualan Bio Product Offered

Table 95. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 96. Hualan Bio Main Business

Table 97. Hualan Bio Latest Developments

Table 98. Hualan Bio Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 99. Takeda Product Offered

Table 100. Takeda Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 101. Takeda Main Business

Table 102. Takeda Latest Developments

Table 103. Takeda Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 104. Kedrion Product Offered

Table 105. Kedrion Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 106. Kedrion Main Business

Table 107. Kedrion Latest Developments

Table 108. Kedrion Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 109. CBPO Product Offered

Table 110. CBPO Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 111. CBPO Main Business

Table 112. CBPO Latest Developments

Table 113. CBPO Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 114. LFB Group Product Offered

Table 115. LFB Group Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 116. LFB Group Main Business

Table 117. LFB Group Latest Developments

Table 118. LFB Group Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 119. Shanghai RAAS Product Offered

Table 120. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 121. Shanghai RAAS Main Business

Table 122. Shanghai RAAS Latest Developments

Table 123. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors

Table 124. Biotest Product Offered

Table 125. Biotest Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 126. Biotest Main Business

Table 127. Biotest Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 128. Biotest Latest Developments

Table 129. HiMedia Product Offered

Table 130. HiMedia Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 131. HiMedia Main Business

Table 132. HiMedia Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 133. HiMedia Latest Developments

Table 134. Ventria (InVitria) Product Offered

Table 135. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 136. Ventria (InVitria) Main Business

Table 137. Ventria (InVitria) Latest Developments

Table 138. Ventria (InVitria) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 139. Merck Product Offered

Table 140. Merck Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)

Table 141. Merck Main Business

Table 142. Merck Latest Developments

Table 143. Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Albumin (as Excipient)

Figure 2. Albumin (as Excipient) Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Albumin (as Excipient) Consumption Growth Rate 2015-2025 (MT)

Figure 5. Global Albumin (as Excipient) Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Human Serum Albumin

Figure 7. Product Picture of Recombinant Albumin

Figure 8. Global Albumin (as Excipient) Consumption Market Share by Type (2015-2020)

Figure 9. Global Albumin (as Excipient) Value Market Share by Type (2015-2020)

Figure 10. Albumin (as Excipient) Consumed in Cell Culture Media

Figure 11. Global Albumin (as Excipient) Market: Cell Culture Media (2015-2020) (MT)

Figure 12. Global Albumin (as Excipient) Market: Cell Culture Media (2015-2020) ($ Millions)

Figure 13. Albumin (as Excipient) Consumed in Medical Supplements

Figure 14. Global Albumin (as Excipient) Market: Medical Supplements (2015-2020) (MT)

Figure 15. Global Albumin (as Excipient) Market: Medical Supplements (2015-2020) ($ Millions)

Figure 16. Albumin (as Excipient) Consumed in Therapeutics

Figure 17. Global Albumin (as Excipient) Market: Therapeutics (2015-2020) (MT)

Figure 18. Global Albumin (as Excipient) Market: Therapeutics (2015-2020) ($ Millions)

Figure 19. Global Albumin (as Excipient) Consumption Market Share by Application (2015-2020)

Figure 20. Global Albumin (as Excipient) Value Market Share by Application (2015-2020)

Figure 21. Global Albumin (as Excipient) Sales Market Share by Company in 2017

Figure 22. Global Albumin (as Excipient) Sales Market Share by Company in 2019

Figure 23. Global Albumin (as Excipient) Revenue Market Share by Company in 2017

Figure 24. Global Albumin (as Excipient) Revenue Market Share by Company in 2019

Figure 25. Global Albumin (as Excipient) Sale Price by Company in 2019

Figure 26. Global Albumin (as Excipient) Consumption Market Share by Regions 2015-2020

Figure 27. Global Albumin (as Excipient) Value Market Share by Regions 2015-2020

Figure 28. Americas Albumin (as Excipient) Consumption 2015-2020 (MT)

Figure 29. Americas Albumin (as Excipient) Value 2015-2020 ($ Millions)

Figure 30. APAC Albumin (as Excipient) Consumption 2015-2020 (MT)

Figure 31. APAC Albumin (as Excipient) Value 2015-2020 ($ Millions)

Figure 32. Europe Albumin (as Excipient) Consumption 2015-2020 (MT)

Figure 33. Europe Albumin (as Excipient) Value 2015-2020 ($ Millions)

Figure 34. Middle East & Africa Albumin (as Excipient) Consumption 2015-2020 (MT)

Figure 35. Middle East & Africa Albumin (as Excipient) Value 2015-2020 ($ Millions)

Figure 36. Americas Albumin (as Excipient) Consumption Market Share by Countries in 2019

Figure 37. Americas Albumin (as Excipient) Value Market Share by Countries in 2019

Figure 38. Americas Albumin (as Excipient) Consumption Market Share by Type in 2019

Figure 39. Americas Albumin (as Excipient) Consumption Market Share by Application in 2019

Figure 40. United States Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 41. United States Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 42. Canada Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 43. Canada Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 44. Mexico Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 45. Mexico Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 46. APAC Albumin (as Excipient) Consumption Market Share by Countries in 2019

Figure 47. APAC Albumin (as Excipient) Value Market Share by Regions in 2019

Figure 48. APAC Albumin (as Excipient) Consumption Market Share by Type in 2019

Figure 49. APAC Albumin (as Excipient) Consumption Market Share by Application in 2019

Figure 50. China Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 51. China Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 52. Japan Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 53. Japan Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 54. Korea Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 55. Korea Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 56. Southeast Asia Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 57. Southeast Asia Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 58. India Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 59. India Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 60. Australia Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 61. Australia Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 62. Europe Albumin (as Excipient) Consumption Market Share by Countries in 2019

Figure 63. Europe Albumin (as Excipient) Value Market Share by Countries in 2019

Figure 64. Europe Albumin (as Excipient) Consumption Market Share by Type in 2019

Figure 65. Europe Albumin (as Excipient) Consumption Market Share by Application in 2019

Figure 66. Germany Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 67. Germany Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 68. France Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 69. France Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 70. UK Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 71. UK Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 72. Italy Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 73. Italy Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 74. Russia Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 75. Russia Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 76. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Countries in 2019

Figure 77. Middle East & Africa Albumin (as Excipient) Value Market Share by Countries in 2019

Figure 78. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Type in 2019

Figure 79. Middle East & Africa Albumin (as Excipient) Consumption Market Share by Application in 2019

Figure 80. Egypt Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 81. Egypt Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 82. South Africa Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 83. South Africa Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 84. Israel Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 85. Israel Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 86. Turkey Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 87. Turkey Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 88. GCC Countries Albumin (as Excipient) Consumption Growth 2015-2020 (MT)

Figure 89. GCC Countries Albumin (as Excipient) Value Growth 2015-2020 ($ Millions)

Figure 90. Global Albumin (as Excipient) Consumption Growth Rate Forecast (2021-2025) (MT)

Figure 91. Global Albumin (as Excipient) Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 92. Americas Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 93. Americas Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 94. APAC Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 95. APAC Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 96. Europe Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 97. Europe Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 98. Middle East & Africa Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 99. Middle East & Africa Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 100. United States Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 101. United States Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 102. Canada Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 103. Canada Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 104. Mexico Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 105. Mexico Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 106. Brazil Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 107. Brazil Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 108. China Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 109. China Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 110. Japan Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 111. Japan Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 112. Korea Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 113. Korea Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 114. Southeast Asia Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 115. Southeast Asia Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 116. India Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 117. India Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 118. Australia Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 119. Australia Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 120. Germany Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 121. Germany Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 122. France Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 123. France Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 124. UK Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 125. UK Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 126. Italy Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 127. Italy Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 128. Russia Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 129. Russia Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 130. Spain Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 131. Spain Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 132. Egypt Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 133. Egypt Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 134. South Africa Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 135. South Africa Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 136. Israel Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 137. Israel Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 138. Turkey Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 139. Turkey Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 140. GCC Countries Albumin (as Excipient) Consumption 2021-2025 (MT)

Figure 141. GCC Countries Albumin (as Excipient) Value 2021-2025 ($ Millions)

Figure 142. CSL Albumin (as Excipient) Market Share (2018-2020)

Figure 143. Albumedix Albumin (as Excipient) Market Share (2018-2020)

Figure 144. Grifols Albumin (as Excipient) Market Share (2018-2020)

Figure 145. Octapharma Albumin (as Excipient) Market Share (2018-2020)

Figure 146. Hualan Bio Albumin (as Excipient) Market Share (2018-2020)

Figure 147. Takeda Albumin (as Excipient) Market Share (2018-2020)

Figure 148. Kedrion Albumin (as Excipient) Market Share (2018-2020)

Figure 149. CBPO Albumin (as Excipient) Market Share (2018-2020)

Figure 150. LFB Group Albumin (as Excipient) Market Share (2018-2020)

Figure 151. Shanghai RAAS Albumin (as Excipient) Market Share (2018-2020)

Figure 152. Biotest Albumin (as Excipient) Market Share (2018-2020)

Figure 153. HiMedia Albumin (as Excipient) Market Share (2018-2020)

Figure 154. Ventria (InVitria) Albumin (as Excipient) Market Share (2018-2020)

Figure 155. Merck Albumin (as Excipient) Market Share (2018-2020)